Recent Updates
Recently added Catalysts
NTRB Positive Sentiment

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

Thursday, August 13, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Nutriband Inc. has announced that its CEO, Gareth Sheridan, will present at the 2026 Georgia Life Sciences Summit on August 26th. This event is part of the CEO spotlight and aims to showcase Georgia's growing role in life sciences innovation. The summit will gather leaders from various sectors including biotechnology and investment.

Market Sentiment Analysis

POSITIVE FACTORS

  • Gareth Sheridan will represent Nutriband at a prestigious summit.
  • The event highlights Georgia's leadership in life sciences innovation.
  • The summit provides networking opportunities with industry leaders.

Full Press Release Details

ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit on Aug 26th as part of the CEO spotlight event. The Georgia Life Sciences Summit brings together leaders from across biotechnology, medical technology, research, manufacturing, and investment to showcase Georgia's emergence as a national leader in life sciences innovation. The Summit...

Frequently Asked Questions

When will Gareth Sheridan present at the summit?

Gareth Sheridan will present on August 26th, 2026.

What is the focus of the Georgia Life Sciences Summit?

The summit focuses on showcasing Georgia's leadership in life sciences innovation.

Who will attend the Georgia Life Sciences Summit?

Leaders from biotechnology, medical technology, research, and investment sectors will attend.

What role does Nutriband play in the summit?

Nutriband's CEO will represent the company as part of the CEO spotlight.

ShareAdd on Google
Tags: NTRB Viatris Investor Conferences Healthcare Nutriband Gareth Sheridan Georgia Life Sciences biotechnology medical technology
Last updated: Aug 13, 2026

Biotech snapshot

Cash runway
$4M liquidity · $0M/mo burn
~20 mo
Low dilution risk